The 22nd Annual South Beach Symposium (SBS), held from Feb. 8-11, 2024, gathered a diverse array of esteemed speakers, enthusiastic attendees, and innovative exhibitors, and proved to be a nexus of learning, collaboration, and inspiration. From thought-provoking discussions led by renowned experts to hands-on workshops and live demonstrations, SBS 2024 brought attendees cutting-edge advancements in the dermatologic space. Read on for highlights of some of the remarkable sessions that made this year’s symposium a standout experience for all who attended.
Key Highlights
Cutaneous Oncology Symposium
The Cutaneous Oncology Symposium kicked off the highly anticipated 2024 SBS following a warm welcome from esteemed co-chairs, Michael H. Gold, MD, and David J. Goldberg, MD, JD. Among the incredible topics featured were talks from renowned expert Aaron S. Farberg, MD, who looked at how molecular profiling and precision medicine can revolutionize the diagnosis and treatment of cutaneous malignancies, and Naiem Issa, MD, PhD, who gave vital insight into the role of dermoscopy and photodocumentation. Joel Claveau, MD, provided an update on what’s in the pipeline for melanoma and NMSCs. Ellen Kim, MD, was present to discuss how to differentiate cutaneous T-cell lymphoma. Dr. Goldberg spoke about superficial radiation therapy and Todd Schlesinger, MD dove into actinic keratosis and photodynamic therapy. As the inaugural session of SBS 2024, the Cutaneous Oncology Symposium laid a solid foundation for the extraordinary educational experience that was to follow.
A Focus on JAK Inhibitors
During the Boxed Warning Toolkit Session, attendees engaged in a comprehensive exploration of critical topics led by associate professor of dermatology at Yale’s Department of Dermatology, Christopher G. Bunick MD, PhD. Alongside distinguished speakers, Ruth Ann Vleugels, MD, MPH, MBA, and George Martin, MD, the session delved into the use of JAK inhibitors in dermatology. With a focus on safety, efficacy, and patient-centered care, experts dissected the intricacies of JAK inhibitor usage, covering patient selection criteria and optimal management strategies.
The exploration of JAK inhibitors remained a point of discussion during Saturday’s session entitled “Biologics vs JAK Inhibitors for Atopic Dermatitis,” offering attendees an in-depth examination of these evolving therapies. Led once again by Dr. Bunick, this time alongside his esteemed Yale colleague, Brett A. King, MD, PhD, the session provided a comparison between biologics and JAK inhibitors for the treatment of atopic dermatitis. Drawing upon their wealth of experience and research, Drs. Bunick and King offered valuable insights, empowering attendees with the knowledge needed to make informed decisions in clinical practice.
Later, Dr. King continued his exploration of the topic with a specialized session entitled “JAK Inhibitors for Alopecia Areata” within the Hair Loss and Restoration Track.
All of these sessions underscored the significance of ongoing discussions surrounding JAK inhibitors and their potential role in shaping the future of dermatological care.
Alopecia Areata in Adolescence
“According to the Patient: Alopecia Areata in Adolescence,” was a CME Satellite Symposium led by Dr. King and Brittany G. Craiglow, MD. This hour-long discussion dove into disease pathogenesis and treatment modalities. The two experts shed light on the profound impact of alopecia areata on the quality of life and mental health of young patients. They further emphasized the importance of holistic patient care and addressing not only the physical manifestations, but also the emotional and psychological toll of the condition.
Practice Management
The practice management session moved away from the clinical aspect of SBS, offering attendees a unique opportunity to explore the operational and business aspects of running a successful dermatology practice. The session, led by Suneel Chilukuri, MD, showcased talks from esteemed speakers Leon H. Kircik, MD, and Dr. Bunick, where attendees learned about the process of initiating clinical trials in their practices, gaining a comprehensive understanding of the benefits and logistics involved. Additionally, Karan Lal, DO, MS, offered advice on leveraging social media platforms to effectively market and grow their practices in the digital age. Furthermore, Brad Glick, DO, MPH, shared innovative approaches for generating extra revenue within dermatology practices, offering actionable tips for maximizing profitability and sustainability. This session proved to be a cornerstone for attendees looking to optimize their practice management strategies and drive success in their dermatological practices.
SBS Specialty Tracks
Anti-Aging and Regenerative Medicine Track
The Anti-Aging and Regenerative Medicine track offered attendees a comprehensive exploration of cutting-edge topics essential to modern dermatology. Led by esteemed experts in the field, including James LaValle, PRh, CCN, Patricia K. Farris, MD, Glynis R. Ablon, MD, Randy Miller, MD, Ted Lain, MD, MBA, and Erika Schwartz, MD, the session covered various topics. From unraveling the role of antioxidants, prebiotics, and probiotics in skincare to dissecting the intricate interplay of nutrition and hormones in aging, attendees were treated to a wealth of invaluable information and evidence-based strategies.
Hair Loss and Restoration Track
Dr. King returned to spearhead the second specialty session, which highlighted the latest developments in hair restoration and transplantation techniques. Joining him were experts Maryanne M. Senna, MD, and Marc Avram, MD, who shared their insights into emerging advancements in the field. Additionally, Crystal Aguh, MD, offered specialist perspectives on cultural considerations for patients with skin of color and providing tips for inclusive and patient-centered care.
Live Patient Demonstrations
The live patient demonstration sessions are always a highlight of SBS. These sessions offer attendees a unique opportunity to witness experts in action and observe their injection techniques up close. Not only do they have the chance to see the latest aesthetic procedures performed live on patients, but these sessions also create a dynamic environment where they can engage with the experts, ask questions, and gain insider tips and tricks.
SBS featured two live patient injections sessions. The first, held on Friday, Feb. 9, was a live body injections session moderated by renowned aesthetic plastic surgeon, Z. Paul Lorence, MD and featured expert injectors, Dr. Chilukuri, Lesley R. Clark Loeser, MD, and Roberta S. Del Campo, MD. The second, live patient facial injections, took place on Sunday, Feb 11, and was moderated by top cosmetic dermatologist, Doris J. Day, MD. It featured expert injectors Shino Bay Aguilera, DO, Robyn Siperstein, MD, and Susan H. Weinkle, MD.
The interactive nature of these live sessions allows for invaluable skill-building and deeper learning that cannot be replicated through lectures alone. Attendees gain first-hand clinical experience in new techniques and approaches that they can immediately incorporate into their own practices. Furthermore, these sessions embody the collaborative spirit of SBS, fostering an environment where knowledge exchange and professional growth thrive.
Masters of Pediatric Dermatology (MOPD) Highlights
In addition to SBS, attendees were also treated to the 32nd annual Masters of Pediatric Dermatology (MOPD) Symposium, held from Feb. 8-9. Led by its founder and renowned pediatric dermatologist, Lawrence A. Schachner, MD, MOPD is dedicated to advancing the field of pediatric dermatology. With a legacy spanning over 30 years, MOPD has provided a vital platform for pediatricians, dermatologists, pediatric dermatologists, nurses, family practitioners, and physician assistants to deepen their knowledge and expertise in pediatric dermatology. Once again, the comprehensive agenda encompassed the latest treatments, best practices, and emerging trends in the diagnosis and management of dermatological conditions in children and adolescents.
Challenging Conditions in Pediatric Dermatology
The MOPD session, “Challenging Conditions in Pediatric Dermatology” proved to be a vital forum for attendees to explore complex dermatological issues affecting children. Among the topics covered in this session, expert Lara Wine Lee, MD, PhD, reviewed the latest therapeutic advancements in managing epidermolysis bullosa and Robert Sidbury, MD, MPH, led an insightful discussion on chronic urticaria. The session reached its pinnacle as a panel of experts, including Dr. Schachner, Dr. Lee, Dr. Sidbury, Hadar Avihai Lev-Tov, MD, MAS, and James R. Treat, MD, navigated through a series of challenging cases, providing their collective expertise and recommendations.
Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis
Renowned pediatric dermatologists, Adelaide A. Hebert, MD, Peter A. Lio, MD, and Dr. Sidbury led Friday morning’s CME Satellite Symposium, “Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis.” This fascinating program offered attendees the latest insights and practical guidance on using these novel medications to treat atopic dermatitis in children. Attendees gained essential perspectives on successfully integrating AHRs into treatment regimens to help relieve symptoms and improve quality of life for pediatric patients. The symposium highlighted the promise of this important new drug class in advancing the care of children with debilitating atopic dermatitis.
JAK Inhibitors in Pediatric Dermatology
Building on the crucial topic of JAK inhibitors, MOPD featured a dedicated session on the use of these medications for specific pediatric skin conditions. Expert speakers, including Dr. Lio, MD., Nanette B. Silverberg, MD, Dr. Craiglow, MD, and Dr. Sidbury, outlined emerging applications of JAK inhibitors for vitiligo, alopecia areata, and atopic dermatitis in children and teens. Guidance was provided on patient selection, monitoring, and managing side effects. Recognizing families’ concerns about safety with newer treatments, the session also covered best practices for addressing parent and patient apprehension surrounding JAK inhibitors.
Hands-On Cadaver Lab
In addition to the enriching SBS and MOPD sessions, the Hands-On Cadaver Lab, held on Saturday, Feb.10, provided a unique and immersive experience for attendees seeking to enhance their proficiency in aesthetic facial procedures. Led by Dr. Lorenc, this hands-on workshop offered a unique opportunity for participants to refine their skills through practical, real-world applications. The room was abuzz with excitement as attendees, ranging from seasoned practitioners to aspiring dermatologists, eagerly immersed themselves in the intricacies of aesthetic injectable techniques. Under the expert guidance of Dr. Lorenc, alongside his colleagues, Jason N. Pozner, MD, and Jonathan Cook, MD, participants honed their abilities, while gaining a deeper understanding of facial anatomy. The overwhelming turnout underscored the enduring popularity and invaluable educational impact of this signature workshop at SBS.
Networking and the Exhibit Hall
Each year SBS aims to deliver an immersive learning experience by showcasing the latest innovations in dermatology. This year’s enhanced exhibit hall exemplified that commitment to cutting-edge education. Spanning a vibrant space, the bustling exhibit hall provided attendees the opportunity to explore new technologies, connect with industry leaders, and discover emerging advancements shaping the future of dermatologic care. Attendees engaged with exhibitors to learn about the most up-to-date products, equipment, and therapies. It was also the perfect networking opportunity, allowing participants to exchange ideas and build relationships with peers.
Looking Ahead
The 22nd annual SBS, alongside the leading MOPD event, once again brought together the best minds in dermatology for an impactful and inspiring few days. From illuminating clinical lectures to interactive discussions, and an energetic exhibit hall, these events offered numerous opportunities for learning and connection. We are grateful to our expert faculty, dedicated attendees, generous sponsors, and enthusiastic exhibitors for making this event such a resounding success.
We look forward to welcoming both familiar faces and new attendees to the 23rd Annual South Beach Symposium in 2025.
